|
COQ6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.58850000112565E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.14989999972148E-07 |
| Normal-vs-Stage2 |
2.324800E-03 |
| Normal-vs-Stage3 |
5.577100E-04 |
| Normal-vs-Stage4 |
1.313210E-01 |
| Stage1-vs-Stage2 |
8.104000E-01 |
| Stage1-vs-Stage3 |
3.897000E-01 |
| Stage1-vs-Stage4 |
8.634400E-01 |
| Stage2-vs-Stage3 |
6.242600E-01 |
| Stage2-vs-Stage4 |
9.431000E-01 |
| Stage3-vs-Stage4 |
8.037000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.52259999953009E-08 |
| Normal-vs-AfricanAmerican |
1.244970E-04 |
| Normal-vs-Asian |
3.302000E-03 |
| Caucasian-vs-AfricanAmerican |
4.968000E-01 |
| Caucasian-vs-Asian |
7.844600E-01 |
| AfricanAmerican-vs-Asian |
6.476800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.40890000011451E-07 |
| Normal-vs-Female |
2.00409999706608E-08 |
| Male-vs-Female |
4.048000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.58038999999999E-05 |
| Normal-vs-Extreme_Weight |
6.14439999990779E-07 |
| Normal-vs-Obese |
4.36589999996961E-06 |
| Normal-vs-Extreme_Obese |
9.038000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.210400E-01 |
| Normal_Weight-vs-Obese |
6.875600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.170200E-02 |
| Extreme_Weight-vs-Obese |
8.901400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.219820E-01 |
| Obese-vs-Extreme_Obese |
4.076400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.641400E-04 |
| Normal-vs-Age(41-60Yrs) |
4.19310000054907E-07 |
| Normal-vs-Age(61-80Yrs) |
5.3053000004244E-07 |
| Normal-vs-Age(81-100Yrs) |
1.369670E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.585400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.998430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.629600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.100000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.906400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.088200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.01660000000081E-05 |
| Normal-VS-Type2 PRCC |
3.71160000000037E-05 |
| Normal-VS-KIRP CIMP |
5.26280130586088E-11 |
| Normal-VS-Unclassified PRCC |
4.0847000000177E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.715200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.15019999968879E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
2.156300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.14179999999243E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.423200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.419400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.56329999999794E-05 |
| Normal-vs-N1 |
1.915250E-03 |
| Normal-vs-N2 |
7.62940000065271E-09 |
| N0-vs-N1 |
3.162200E-01 |
| N0-vs-N2 |
1.262540E-03 |
| N1-vs-N2 |
1.295130E-03 |
|
|
